Duration of Dual Antiplatelet Therapy after Implantation of Drug-Eluting Stents
Top Cited Papers
- 16 April 2010
- journal article
- research article
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 362 (15) , 1374-1382
- https://doi.org/10.1056/nejmoa1001266
Abstract
The potential benefits and risks of the use of dual antiplatelet therapy beyond a 12-month period in patients receiving drug-eluting stents have not been clearly established.Keywords
This publication has 25 references indexed in Scilit:
- Delayed Arterial Healing and Increased Late Stent Thrombosis at Culprit Sites After Drug-Eluting Stent Placement for Acute Myocardial Infarction PatientsCirculation, 2008
- 2007 Focused Update of the ACC/AHA/SCAI 2005 Guideline Update for Percutaneous Coronary InterventionCirculation, 2008
- Outcomes associated with drug-eluting and bare-metal stents: a collaborative network meta-analysisPublished by Elsevier ,2007
- Long-Term Outcomes with Drug-Eluting Stents versus Bare-Metal Stents in SwedenNew England Journal of Medicine, 2007
- Clopidogrel Use and Long-term Clinical Outcomes After Drug-Eluting Stent ImplantationJAMA, 2007
- Late Thrombosis of Drug-Eluting Stents: A Meta-Analysis of Randomized Clinical TrialsPublished by Elsevier ,2006
- Outcomes of 6906 Patients Undergoing Percutaneous Coronary Intervention in the Era of Drug-Eluting StentsCirculation, 2006
- Late Clinical Events After Clopidogrel Discontinuation May Limit the Benefit of Drug-Eluting StentsJournal of the American College of Cardiology, 2006
- Frequency of and Risk Factors for Stent Thrombosis After Drug-Eluting Stent Implantation During Long-Term Follow-UpThe American Journal of Cardiology, 2006
- Incidence, Predictors, and Outcome of Thrombosis After Successful Implantation of Drug-Eluting StentsJAMA, 2005